Mismatch Repair (MMR) Deficiency in Colorectal Cancer
What is microsatellite instability or MSI?
MMR by IHC vs MSI by PCR
Single-agent PD-1 blockade as curative-intent treatment in mismatch repair-deficient LARC
Dr. Sinicrope on Mismatch Repair-Deficient Patients With Metastatic Colorectal Cancer
Advancing Treatment Options for Mismatch Repair-Deficient Metastatic Colorectal Cancers
Dr. Jennifer Wu on Immunotherapy in Mismatch Repair Deficient CRC
Improving anti-CTLA4 efficacy in neuroblastoma via the induction of mismatch repair deficiency
Dr. Cercek on Induction Chemotherapy in Mismatch Repair Deficient Rectal Cancer
Immuno-oncology: Cold to Hot Tumours
Debate: MSI High Colon Cancer - Upfront Chemotherapy
Mismatch Repair Deficiency in Glioma Patients
Effects of Mismatch Repair Deficiency and Microsatellite Instability on Gastric Cancer Outcomes
Preliminary Findings From the NCI-MATCH Trial for Mismatch Repair-Deficient
Stanford Cancer Institute Breakthroughs in Cancer: Luis Diaz, MD
What is mismatch repair deficiency and how is it treated?
Episode 60 Detecting Deficient Mismatch Repair in Solid Neoplasms
Mismatch Repair / Microsatellite Instability
Colorectal Cancer: MSI Testing to All Patients and How to Test
Biomarkers of treatment response in patients with MMR-proficient CRC